Antoine Engelen
Overview
Explore the profile of Antoine Engelen including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
5
Citations
115
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Meduri B, Baldissera A, Iotti C, Scheijmans L, Stam M, Parisi S, et al.
J Clin Oncol
. 2023 Jan;
41(12):2201-2210.
PMID: 36623246
Purpose: The results in terms of side effects vary among the published accelerated partial-breast irradiation (APBI) studies. Here, we report the 5-year results for cosmetic outcomes and toxicity of the...
2.
Poortmans P, Struikmans H, De Brouwer P, Weltens C, Fortpied C, Kirkove C, et al.
J Natl Cancer Inst
. 2021 Jul;
113(10):1360-1368.
PMID: 34320651
Background: Uncertainty about the benefit-risk ratio of regional lymph node irradiation led to varying clinical protocols. We investigated long-term late side effects after internal mammary and medial supraclavicular (IM-MS) lymph...
3.
Bolla M, Neven A, Maingon P, Carrie C, Boladeras A, Andreopoulos D, et al.
J Clin Oncol
. 2021 Jul;
39(27):3022-3033.
PMID: 34310202
Purpose: The European Organisation for Research and Treatment of Cancer (EORTC) trial 22991 (NCT00021450) showed that 6 months of concomitant and adjuvant androgen suppression (AS) improves event- (EFS, Phoenix) and...
4.
Poortmans P, Weltens C, Fortpied C, Kirkove C, Peignaux-Casasnovas K, Budach V, et al.
Lancet Oncol
. 2020 Nov;
21(12):1602-1610.
PMID: 33152277
Background: 10-year results from several studies showed improved disease-free survival and distant metastasis-free survival, reduced breast cancer-related mortality, and variable effects on overall survival with the addition of partial or...
5.
Evers J, Kupper N, Kessing D, Davits R, Engelen A, Poortmans P, et al.
Urology
. 2010 Sep;
76(5):1150-6.
PMID: 20869105
Objectives: To prospectively investigate the influence of 3-month neoadjuvant hormonal therapy (NHT) before brachytherapy (BT) for low-risk prostate cancer (PCa) on urinary function and health-related quality of life (HRQL). Methods:...